>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

RH +15.5%, ( guides Q4 EPS and revenues above consensus; authorizes a $300 million common share repurchase program),AAOI +11.5%, OLED +10.4%
MTZ +9.3%, TPC +7.3%, RMAX +6.7%, SB +5.1%, INWK +5.1%,EGO +4.7%, SGY +4.7%, VICR +4.2%, PSO +3.6%, RDC +3.4%,PACD +3.1%, WMAR +3.1%
FL +2.7%, BJRI +2.5%, JWN +2.5%, EBS +2.4%, DYN +2.4%, AL +1.9%, MELI +1.8%, MAIN +1.5%, AGO +1.5%, PEG +1.3%, CLMT +1.1%, INTU +1%
AINC +0.9%, STMP +0.9%

Select metals/mining stocks trading higher:

SBGL +3.7%, AUY +3.2%, AG +3.1%, SLW +2%, NEM +2%, IAG+1.9%, ABX +1.8%, GG +1.7%, HMY +1.4%, GDX +1.3%, AU +1%,

Other news:

CEMP +44.4% (positive topline results from a phase 3 study of oral fusidic acid )
IPCI +30.2% (receives FDA approval for its ANDA for metformin hydrochloride extended release tablets)
AXDX +22.2% (FDA allows marketing of the PhenoTest BC Kit, performed on the Pheno System )
EARS +13% (FDA has granted Fast Track designation for AM-111)
INCY +5.1% (to join S&P 500)
NVLS +4.4% (announces its Phase 2 trial evaluating cavosonstat at a dose of 400 mg in adult patients with CF who were being treated w/ Kalydeco did not meet its primary endpoint )
DFT +4.3% (announces an 'at-the-market' program through which it may issue and sell, from time to time, up to an aggregate of $200 mln of its common shares)
BATS +2.2% (higher following S&P index change announcement - CBOE to join S&P 500 after acquiring BATS)
CONE +2.2% (will replace CLARCOR in the S&P MidCap 400)
NUS +2% (will replace Equity One in the S&P MidCap 400)
CXW +1.7% (reports that the DOJ reverses Obama decision on private prisons)
GEO +1.3% (reports that the DOJ reverses Obama decision on private prisons)

Analyst comments: